These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 16216978

  • 1. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
    Kilic A, Velic A, De Windt LJ, Fabritz L, Voss M, Mitko D, Zwiener M, Baba HA, van Eickels M, Schlatter E, Kuhn M.
    Circulation; 2005 Oct 11; 112(15):2307-17. PubMed ID: 16216978
    [Abstract] [Full Text] [Related]

  • 2. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S, Kilić A, Völker K, Leineweber K, Dybkova N, Maier LS, Brodde OE, Kuhn M.
    Cardiovasc Res; 2007 Mar 01; 73(4):678-88. PubMed ID: 17107670
    [Abstract] [Full Text] [Related]

  • 3. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY, Iwata Y, Arai Y, Komamura K, Wakabayashi S.
    Circ Res; 2008 Oct 10; 103(8):891-9. PubMed ID: 18776042
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K.
    Circulation; 2005 Jun 14; 111(23):3095-104. PubMed ID: 15939815
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H, Kuwahara K, Nishida M, Jian Z, Rong X, Kiyonaka S, Kuwabara Y, Kurose H, Inoue R, Mori Y, Li Y, Nakagawa Y, Usami S, Fujiwara M, Yamada Y, Minami T, Ueshima K, Nakao K.
    Circ Res; 2010 Jun 25; 106(12):1849-60. PubMed ID: 20448219
    [Abstract] [Full Text] [Related]

  • 6. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
    Kirchhof P, Fabritz L, Kilić A, Begrow F, Breithardt G, Kuhn M.
    J Mol Cell Cardiol; 2004 May 25; 36(5):691-700. PubMed ID: 15135664
    [Abstract] [Full Text] [Related]

  • 7. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, Kuhn M.
    J Clin Invest; 2003 May 25; 111(9):1399-407. PubMed ID: 12727932
    [Abstract] [Full Text] [Related]

  • 8. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling.
    Kilić A, Bubikat A, Gassner B, Baba HA, Kuhn M.
    Endocrinology; 2007 Sep 25; 148(9):4162-9. PubMed ID: 17510245
    [Abstract] [Full Text] [Related]

  • 9. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy.
    Chen S, Khan ZA, Karmazyn M, Chakrabarti S.
    Diabetes Metab Res Rev; 2007 Jul 25; 23(5):356-67. PubMed ID: 17024690
    [Abstract] [Full Text] [Related]

  • 10. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
    Ennis IL, Garciarena CD, Escudero EM, Pérez NG, Dulce RA, Camilión de Hurtado MC, Cingolani HE.
    Can J Physiol Pharmacol; 2007 Jul 25; 85(3-4):301-10. PubMed ID: 17612638
    [Abstract] [Full Text] [Related]

  • 11. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
    Kishimoto I, Rossi K, Garbers DL.
    Proc Natl Acad Sci U S A; 2001 Feb 27; 98(5):2703-6. PubMed ID: 11226303
    [Abstract] [Full Text] [Related]

  • 12. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, Okano I, Kawano Y, Kohno M, Miyazato M, Nakao K, Kangawa K.
    Circulation; 2008 May 06; 117(18):2329-39. PubMed ID: 18443239
    [Abstract] [Full Text] [Related]

  • 13. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
    Kilić A, Javadov S, Karmazyn M.
    J Mol Cell Cardiol; 2009 Mar 06; 46(3):360-9. PubMed ID: 19111554
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M, Voss M, Mitko D, Stypmann J, Schmid C, Kawaguchi N, Grabellus F, Baba HA.
    Cardiovasc Res; 2004 Nov 01; 64(2):308-14. PubMed ID: 15485690
    [Abstract] [Full Text] [Related]

  • 15. Antihypertrophic effect of Na+/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species.
    Javadov S, Baetz D, Rajapurohitam V, Zeidan A, Kirshenbaum LA, Karmazyn M.
    J Pharmacol Exp Ther; 2006 Jun 01; 317(3):1036-43. PubMed ID: 16513848
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M, Wang S, Aoyagi T, Oikawa R, Sanbe A, Takeo S, Tanoue A.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):89-97. PubMed ID: 17275806
    [Abstract] [Full Text] [Related]

  • 17. Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure.
    Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, Coronel R, Opthof T, Fiolet JW.
    Cardiovasc Res; 2005 Jan 01; 65(1):83-92. PubMed ID: 15621036
    [Abstract] [Full Text] [Related]

  • 18. Sodium hydrogen exchange 1 (NHE-1) regulates connexin 43 expression in cardiomyocytes via reverse mode sodium calcium exchange and c-Jun NH2-terminal kinase-dependent pathways.
    Stanbouly S, Kirshenbaum LA, Jones DL, Karmazyn M.
    J Pharmacol Exp Ther; 2008 Oct 01; 327(1):105-13. PubMed ID: 18650245
    [Abstract] [Full Text] [Related]

  • 19. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
    Khoo MS, Li J, Singh MV, Yang Y, Kannankeril P, Wu Y, Grueter CE, Guan X, Oddis CV, Zhang R, Mendes L, Ni G, Madu EC, Yang J, Bass M, Gomez RJ, Wadzinski BE, Olson EN, Colbran RJ, Anderson ME.
    Circulation; 2006 Sep 26; 114(13):1352-9. PubMed ID: 16982937
    [Abstract] [Full Text] [Related]

  • 20. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
    Guo J, Gan XT, Haist JV, Rajapurohitam V, Zeidan A, Faruq NS, Karmazyn M.
    Circ Heart Fail; 2011 Jan 26; 4(1):79-88. PubMed ID: 20971938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.